Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRGF for meniscal degeneration
IRCT20210423051054N2Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Mar 2026
- Modality
- Small Molecules, Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of PRGF-Endoret and naproxen in Meniscal Degeneration and knee osteoarthritis (OA) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Grade of meniscal degeneration on MRI. Started Mar 2026; status: completed.
02
Drugs
PRGF-Endoretnaproxen
03
Conditions
Meniscal Degenerationknee osteoarthritis (OA)
Beyond the preview
Go deeper on IRCT20210423051054N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210423051054N2.